Sarcoidosis respiratory care

Sarcoidosis respiratory care focuses on a systemic disease in which granulomas—organized clusters of immune cells—form within lung tissue, impairing gas exchange and lung mechanics. Patients often present with cough, chest discomfort, breathlessness, or fatigue, though some remain asymptomatic and are identified through incidental imaging findings. The course of disease varies widely, with some cases resolving spontaneously while others progress to chronic interstitial lung disease and fibrosis. Accurate diagnosis relies on a combination of imaging, pulmonary function testing, and biopsy, with attention to excluding alternative causes of granulomatous inflammation.

Effective management of sarcoidosis respiratory care involves balancing treatment benefits against potential side effects. Corticosteroids remain the mainstay of therapy, with immunosuppressive agents such as methotrexate or azathioprine reserved for refractory cases. Supportive interventions, including pulmonary rehabilitation, vaccination, and oxygen supplementation, contribute to improved quality of life. Long-term follow-up ensures monitoring for disease progression and treatment-related complications. Multidisciplinary collaboration between pulmonologists, rheumatologists, and radiologists supports individualized care, while advances in molecular research are opening new possibilities for targeted therapies in sarcoidosis.